Director/PDMR Shareholding

GlaxoSmithKline PLC 14 February 2008 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons The Administrators of the GlaxoSmithKline Performance Share Plan notified the Company and the under-mentioned persons on 14 February 2008 of an increase in their notional interests in Ordinary shares at a price of £12.38 per share and Ordinary Share ADRs at a price of $51.25 per ADR following the notional re-investment of the dividend paid to shareholders on 10 January 2008. Ordinary shares ADRs Dr J-P Garnier 7,217.84 Mr J S Heslop 2,405.18 Dr M Slaoui 429.55 729.95 Mrs C E Bruck Slaoui 37.41 16.61 Mr R M Bondy 2,559.41 Mr J M Clarke 1,979.56 Mr M Dunoyer 963.94 Mr E J Gray 392.22 Dr R G Greig 822.02 Mr D Learmouth 352.75 Mr W C Louv 380.89 Mr D J Phelan 1,265.91 Dr D Pulman 822.02 Mr D M Stout 3,015.28 Mr C Viehbacher 1,308.23 Mr A P Witty 2,644.93 The notional dividends accrued will be paid out in proportion to the percentage of participants' Performance Share Plan holdings that vest following the end of the relevant three year measurement period. This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a). S M Bicknell Company Secretary 14 February 2008 This information is provided by RNS The company news service from the London Stock Exchange

Companies

GSK (GSK)
UK 100

Latest directors dealings